Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
08 2023
Historique:
revised: 26 03 2023
received: 26 10 2022
accepted: 23 05 2023
medline: 31 7 2023
pubmed: 11 7 2023
entrez: 11 7 2023
Statut: ppublish

Résumé

Transcatheter aortic valve implantation (TAVI) has become an alternative to surgical aortic valve replacement for patients with symptomatic severe aortic stenosis in elderly and comorbid population. Significant improvement in heart function has been observed in patients undergoing TAVI, but numerous patients are readmitted to hospital for heart failure (HF). Moreover, repeat HF hospitalization is strongly associated with an adverse prognosis and increases the financial burden of health care. Although studies have identified pre-existing and post-procedural factors that contribute to HF hospitalization after TAVI, there is a paucity of data regarding optimal post-procedural pharmacological treatments. This review aims to provide an overview of the current understanding of mechanisms, determinants, and potential treatments of HF following TAVI. We first review the pathophysiology of left ventricular (LV) remodelling, coronary microcirculation disorder, and endothelial dysfunction in patients with aortic stenosis and then examine the impact of TAVI on these conditions. We then present evidence of various factors and complications that may interplay with LV remodelling and contribute to HF events after TAVI. Next, we describe the triggers and predictors of early and late HF rehospitalizations following TAVI. Lastly, we discuss the potential of conventional pharmacological treatments, including renin-angiotensin blockers, beta-blockers, and diuretics in TAVI patients. The paper explores the potential of newer drugs, including sodium-glucose co-transporter 2 inhibitors, anti-inflammatory drugs, and ion supplementation. Comprehensive knowledge in this field may aid in recognizing successful existing therapies, developing effective new treatments, and establishing dedicated patient care strategies during follow-up after TAVI.

Identifiants

pubmed: 37430483
doi: 10.1002/ehf2.14435
pmc: PMC10375170
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2183-2199

Informations de copyright

© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Semin Thorac Cardiovasc Surg. 2021 Summer;33(2):316-325
pubmed: 32621964
Circulation. 2017 Jan 17;135(3):280-296
pubmed: 27821539
ESC Heart Fail. 2023 Aug;10(4):2183-2199
pubmed: 37430483
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2119-2129
pubmed: 31629743
Eur J Heart Fail. 2021 Feb;23(2):250-258
pubmed: 32729170
ESC Heart Fail. 2021 Apr;8(2):1408-1416
pubmed: 33580746
J Am Soc Echocardiogr. 2018 Oct;31(10):1101-1108
pubmed: 30107957
J Am Heart Assoc. 2021 Feb 2;10(3):e014481
pubmed: 33459031
J Am Soc Echocardiogr. 2021 Jul;34(7):735-743
pubmed: 33652083
Cardiovasc Revasc Med. 2021 Nov;32:35-40
pubmed: 33436346
JACC Cardiovasc Interv. 2018 Oct 22;11(20):2019-2031
pubmed: 30154062
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3065-3073
pubmed: 35550725
JACC Cardiovasc Interv. 2021 Jan 25;14(2):211-220
pubmed: 33478639
J Cardiovasc Magn Reson. 2020 Jun 1;22(1):41
pubmed: 32475350
Circulation. 1984 May;69(5):855-65
pubmed: 6231136
Struct Heart. 2022 Nov 14;7(2):100118
pubmed: 37275584
Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):476-484
pubmed: 34791101
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Int J Cardiol. 2020 Jan 15;299:228-234
pubmed: 31353154
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
Circ Cardiovasc Imaging. 2021 Aug;14(8):e012364
pubmed: 34387097
JACC Heart Fail. 2018 Jan;6(1):1-7
pubmed: 29284577
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Eur Heart J. 2017 May 1;38(17):1285-1293
pubmed: 27744287
Eur Heart J. 2016 Jul 21;37(28):2276-86
pubmed: 26787441
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):798-805
pubmed: 28988432
Front Cardiovasc Med. 2021 Mar 22;8:645693
pubmed: 33829049
Clin Res Cardiol. 2019 Nov;108(11):1258-1265
pubmed: 31049679
EuroIntervention. 2015 Apr;10(12):1456-63
pubmed: 25287265
Circulation. 2009 Aug 18;120(7):577-84
pubmed: 19652094
N Engl J Med. 2019 Dec 26;381(26):2497-2505
pubmed: 31733140
J Am Coll Cardiol. 2022 Aug 23;80(8):783-800
pubmed: 35595203
J Am Coll Cardiol. 2020 Dec 22;76(25):2940-2951
pubmed: 33334422
J Am Heart Assoc. 2020 Jun 16;9(12):e014463
pubmed: 32517527
ESC Heart Fail. 2022 Feb;9(1):133-145
pubmed: 34964300
JACC Cardiovasc Interv. 2021 Jul 12;14(13):1466-1477
pubmed: 34238557
Cardiovasc Res. 2011 Mar 1;89(4):754-65
pubmed: 21075756
J Cardiovasc Magn Reson. 2022 Jul 28;24(1):45
pubmed: 35897100
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
Eur Heart J. 2020 Feb 21;41(8):943-954
pubmed: 31711153
Circulation. 2019 Mar 5;139(10):1289-1299
pubmed: 30586730
JACC Cardiovasc Interv. 2020 Jun 8;13(11):1303-1311
pubmed: 32499020
Cardiovasc Diabetol. 2020 Feb 18;19(1):19
pubmed: 32070346
Catheter Cardiovasc Interv. 2020 Dec;96(7):E711-E722
pubmed: 32198810
Thromb Haemost. 2020 Sep;120(9):1330-1338
pubmed: 32726854
Circ Rep. 2021 Apr 7;3(5):286-293
pubmed: 34007943
J Am Heart Assoc. 2020 Sep 15;9(18):e016911
pubmed: 32893727
Rev Esp Cardiol (Engl Ed). 2020 May;73(5):383-392
pubmed: 31501029
Circulation. 1989 Apr;79(4):744-55
pubmed: 2522356
Catheter Cardiovasc Interv. 2021 May 1;97(6):E875-E886
pubmed: 32926552
Cardiovasc Diabetol. 2021 May 7;20(1):100
pubmed: 33962654
Eur J Heart Fail. 2022 Mar;24(3):581-588
pubmed: 34693613
J Am Soc Echocardiogr. 2014 Nov;27(11):1133-42
pubmed: 25125314
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
Eur Heart J Cardiovasc Imaging. 2021 Oct 19;22(11):1295-1303
pubmed: 33377480
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2426-2436
pubmed: 29217006
Future Cardiol. 2021 Mar;17(2):337-345
pubmed: 33590775
J Am Coll Cardiol. 2019 Apr 23;73(15):1931-1944
pubmed: 30999996
Eur J Heart Fail. 2018 Jan;20(1):125-133
pubmed: 28436136
Eur J Heart Fail. 2019 Feb;21(2):172-181
pubmed: 30328215
J Am Coll Cardiol. 2012 Jun 5;59(23):2068-74
pubmed: 22483326
Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):39-46
pubmed: 28158582
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2155-2168
pubmed: 31699377
Circ Heart Fail. 2021 Jan;14(1):e006979
pubmed: 33464950
Eur Heart J. 2020 Aug 1;41(29):2771-2781
pubmed: 31899484
J Am Coll Cardiol. 2018 Oct 30;72(18):2139-2148
pubmed: 30360823
N Engl J Med. 2012 May 3;366(18):1696-704
pubmed: 22443478
Circ J. 2020 Sep 25;84(10):1875-1883
pubmed: 32879221
J Am Coll Cardiol. 2022 Apr 12;79(14):1340-1351
pubmed: 35393014
Circ Cardiovasc Interv. 2013 Dec;6(6):604-14
pubmed: 24221391
Eur Heart J. 2017 Oct 07;38(38):2879-2887
pubmed: 29019612
Cardiovasc Diabetol. 2017 Jan 13;16(1):9
pubmed: 28086951
Int J Cardiol. 2018 Nov 1;270:83-88
pubmed: 30219541
Am J Cardiol. 2020 Nov 15;135:181-182
pubmed: 32858026
Open Heart. 2020 Jul;7(2):
pubmed: 32641381
Eur Heart J. 2021 Nov 1;42(41):4207-4208
pubmed: 34529759
Eur Heart J. 2021 Jul 21;42(28):2745-2760
pubmed: 33961006
J Am Heart Assoc. 2016 Feb 08;5(2):
pubmed: 26857069
Thromb Haemost. 2018 May;118(5):893-905
pubmed: 29590670
Heart. 2019 Dec;105(23):1818-1824
pubmed: 31467152
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
JACC Cardiovasc Interv. 2022 Aug 22;15(16):1664-1674
pubmed: 35981841
Can J Cardiol. 2020 Jul;36(7):1112-1120
pubmed: 32470334
Circulation. 2019 Nov 19;140(21):1693-1702
pubmed: 31434508
J Am Coll Cardiol. 2019 Aug 6;74(5):631-641
pubmed: 31370954
JACC Cardiovasc Imaging. 2023 Mar;16(3):298-310
pubmed: 36648055
Circ Cardiovasc Interv. 2020 Jul;13(7):e008959
pubmed: 32600108
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
JACC Cardiovasc Interv. 2018 Sep 10;11(17):1746-1756
pubmed: 30190063
Antioxid Redox Signal. 2019 Aug 10;31(5):420-426
pubmed: 30569733
Eur Heart J. 2020 May 21;41(20):1903-1914
pubmed: 32049275
J Cardiovasc Magn Reson. 2020 Jun 22;22(1):46
pubmed: 32564773
N Engl J Med. 2016 Jul 28;375(4):335-44
pubmed: 27464202
Eur Heart J. 2018 Jul 21;39(28):2659-2667
pubmed: 29741615
J Nucl Cardiol. 2021 Apr;28(2):579-588
pubmed: 31044406
J Am Soc Echocardiogr. 2019 Sep;32(9):1058-1066.e2
pubmed: 31311704
Cardiovasc Diabetol. 2021 Mar 16;20(1):65
pubmed: 33726768
JACC Cardiovasc Imaging. 2019 Apr;12(4):577-587
pubmed: 29454762
JACC Cardiovasc Imaging. 2019 Feb;12(2):283-296
pubmed: 30732723
Cardiovasc Diabetol. 2019 Feb 7;18(1):16
pubmed: 30732594
Int J Cardiol. 2017 Oct 1;244:93-99
pubmed: 28645804
J Am Coll Cardiol. 2023 Feb 28;81(8):743-752
pubmed: 36813373
Catheter Cardiovasc Interv. 2018 Jan 1;91(1):135-147
pubmed: 28963761
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548
Eur Heart J. 2022 Aug 1;43(29):2767-2769
pubmed: 35653690
J Cardiovasc Magn Reson. 2021 Mar 1;23(1):15
pubmed: 33641670
Front Cardiovasc Med. 2021 Mar 18;8:623146
pubmed: 33816574
Int J Cardiol. 2021 Jul 1;334:96
pubmed: 33933512
J Am Coll Cardiol. 2017 Jul 4;70(1):42-55
pubmed: 28662806
Cardiovasc Diabetol. 2019 Aug 20;18(1):107
pubmed: 31429767
J Am Coll Cardiol. 2016 May 24;67(20):2349-2358
pubmed: 27199058
Catheter Cardiovasc Interv. 2022 Apr;99(5):1582-1589
pubmed: 35043554
J Am Soc Echocardiogr. 2022 Aug;35(8):791-800.e4
pubmed: 35301093
J Am Coll Cardiol. 2000 Oct;36(4):1131-41
pubmed: 11028462
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007451
pubmed: 29914867
N Engl J Med. 2018 Sep 13;379(11):1007-1016
pubmed: 30145929
Front Cardiovasc Med. 2022 Sep 20;9:950437
pubmed: 36204567
Eur Heart J. 2012 Jun;33(12):1459-68
pubmed: 22285582
JACC Cardiovasc Interv. 2021 Oct 25;14(20):2246-2256
pubmed: 34600873
EuroIntervention. 2023 Jun 19;19(3):256-266
pubmed: 36950893
Eur J Cardiothorac Surg. 2019 Jul 1;56(1):44-54
pubmed: 30657945
EuroIntervention. 2014 Jan 22;9(9):1042-9
pubmed: 24168931
Circulation. 2018 Jul 3;138(1):80-98
pubmed: 29967232
J Thorac Cardiovasc Surg. 2011 Sep;142(3):e77-83
pubmed: 21353251
Eur Heart J. 2017 Dec 01;38(45):3351-3358
pubmed: 29020232
J Am Coll Cardiol. 2021 Jan 19;77(2):128-139
pubmed: 33181246
Circulation. 2021 Aug 24;144(8):615-637
pubmed: 34157861
J Am Heart Assoc. 2020 Mar 3;9(5):e015133
pubmed: 32102615
Int J Cardiol. 2023 Jan 1;370:112-121
pubmed: 36370873
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811

Auteurs

Kensuke Matsushita (K)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
UMR1260 INSERM, Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France.

Benjamin Marchandot (B)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Antonin Trimaille (A)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
UMR1260 INSERM, Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France.

Sandy Hmadeh (S)

UMR1260 INSERM, Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France.

Marion Kibler (M)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Joe Heger (J)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Adrien Carmona (A)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Sebastien Hess (S)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Antje Reydel (A)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Laurence Jesel (L)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
UMR1260 INSERM, Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France.

Patrick Ohlmann (P)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.

Valerie Schini-Kerth (V)

UMR1260 INSERM, Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France.

Olivier Morel (O)

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France.
UMR1260 INSERM, Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH